Improving communication and decision-making for parents in neonatal care
Improving Shared Decision Making on the Neonatal Unit Through Assessment of Parental Experiences (The ShAPE Study)
This study is trying to see how well parents of newborns in neonatal care feel involved in decisions about their babies' treatments, so they can improve communication between parents and doctors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Sex | All |
| Sponsor | East Kent Hospitals University NHS Foundation Trust Government |
| Locations | 1 site (Ashford, Kent) |
| Trial ID | NCT06035640 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on enhancing shared decision-making (SDM) in neonatal units by assessing parental experiences. It aims to support parents of infants who have undergone specific treatments while in neonatal care, such as blood transfusions or pharmacotherapy. By conducting interviews, the study seeks to gather insights on how effectively parents are involved in clinical decisions regarding their infants' care. The findings will help improve communication strategies between parents and healthcare providers in high-stress situations.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of infants who have received specific treatments in a neonatal unit and have been discharged for at least four weeks.
Not a fit: Patients whose infants have not received the specified treatments or who were discharged less than four weeks ago may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved communication and decision-making processes for parents, ultimately enhancing the care experience for families in neonatal units.
How similar studies have performed: While the approach of enhancing shared decision-making in neonatal care is gaining attention, this specific study's methodology is relatively novel and has not been extensively tested in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parent of an Infant who, whilst on a neonatal unit, has received either; a transfusion of blood products, pharmacotherapy for persistent ductus arteriosus or corticosteroid therapy for chronic lung disease Exclusion Criteria: * The infant must have received the above treatments within the last 6 months prior to interview AND have been discharged from neonatal care for at least 4 weeks
Where this trial is running
Ashford, Kent
- William Harvey Hospital — Ashford, Kent, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Daniel Keen
- Email: danielkeen@nhs.net
- Phone: 01233633331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.